Novel pseudosymmetric inhibitors of HIV-1 protease

Novel pseudosymmetric inhibitors of HIV-1 protease Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains Synthesis of PotentC₂-Symmetric, Diol-Based HIV-1 Protease Inhibitors. Investigation of Thioalkyl and Thioaryl P1/P1‘ Substituents Design and Synthesis of New PotentC₂-Symmetric HIV-1 Protease Inhibitors. Use of<scp>l</scp>-Mannaric Acid as a Peptidomimetic Scaffold Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands Functionalized aliphatic P2/P2′ analogs of HIV-1 protease inhibitor DMP323 Rational design of irreversible, pseudo-C2-symmetric hiv-1 protease inhibitors Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance Novel inhibitors of HIV protease Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl design